Cardiovascular Calcification Market Analysis

Cardiovascular calcification is the leading health disorder that leads to the passive degenerative process mainly occurring due to deterioration of tissues caused by the stress and strain of cardiac function. It is observed that it is highly prevalent in patients with chronic kidney disease and is predictive of cardiovascular disease (CVD).
Cardiovascular calcification is triggered by chronic inflammatory disorders such as chronic kidney disease (CKD), type 2 diabetes (T2D), and atherosclerosis that are associated with high prevalence of morbidity and mortality. As of now there are no drug therapies against cardiovascular calcification, the only treatment option is surgery. Some of the risk factors associated with Cardiovascular Calcification includes age, sex, pulse pressure, number of pack-years of smoking, systolic blood pressure, diabetes mellitus, waist circumference, kidney function and many others.

DelveInsight's "Cardiovascular Calcification Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Cardiovascular Calcification Market, historical and forecasted epidemiology, the pipeline insight as well as the Cardiovascular Calcification market size and shares analysis in the seven major markets (7MM) (i.e. the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

For more details on Cardiovascular Calcification Market Insights, Epidemiology, and Pipeline Analysis, visit:
https://www.delveinsight.com/report-store/cardiovascular-calcification-market